ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10592	Companies
224605	Keywords
153322	Articles
118803	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 10/03/2024 at 08:30, 1 year 8 months ago

Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance
Abivax announces positive interim results of obefazimod in ulcerative colitis patients after 2 years, showing maintenance of remission and safety profile consistency

Abivax Obefazimod Ulcerative Colitis Safety Efficacy
BRIEF

published on 09/26/2024 at 08:35, 1 year 8 months ago

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024

Abivax Obefazimod Ulcerative Colitis Phase 2b Study UEG Week 2024
PRESS RELEASE

published on 09/26/2024 at 08:30, 1 year 8 months ago

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024
Abivax to present Phase 2b trial results of obefazimod in ulcerative colitis at UEG Week 2024, showcasing efficacy and safety data for potential oral therapy

Abivax Obefazimod Ulcerative Colitis Clinical Trial UEG Week 2024
BRIEF

published on 09/25/2024 at 22:06, 1 year 8 months ago

Abivax Announces Ulcerative Colitis Combination Therapy Strategy and Preclinical Data

Obefazimod Ulcerative Colitis Preclinical Data Combination Therapy Etrasimod
PRESS RELEASE

published on 09/25/2024 at 22:01, 1 year 8 months ago

Abivax Provides Update on Ulcerative Colitis Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease Mouse Model
Abivax announces preclinical data of Obefazimod and Etrasimod combination therapy in IBD mouse model, aiming to break through efficacy ceiling in UC treatment. More updates expected in Q4 2024

Abivax Obefazimod Preclinical Data Etrasimod IBD Mouse Model
BRIEF

published on 09/19/2024 at 18:05, 1 year 8 months ago

ABIVAX: Number of shares and voting rights as of August 31, 2024

Euronext Paris Share Capital Voting Rights Biotechnology Abivax
BRIEF

published on 09/09/2024 at 23:01, 1 year 9 months ago

Statement by Marc de Garidel on Abivax's 2024 Half-Year Financial Report

Financial Report Abivax Transparency IFRS Heritage
BRIEF

published on 09/09/2024 at 22:40, 1 year 9 months ago

ABIVAX presents its 2024 half-year results

Cybersecurity Abivax Half-year Results Internal Control Failures
BRIEF

published on 09/09/2024 at 22:06, 1 year 9 months ago

Abivax financial results for the first half of 2024

Financial Results Biotechnology Abivax First Half Of 2024 Immune Mechanisms
PRESS RELEASE

published on 09/09/2024 at 22:01, 1 year 9 months ago

Abivax presents first-half 2024 financial results
Abivax presents first-half 2024 financial results with a cash balance of EUR 222M at June 30, 2024. The company focuses on developing therapies for chronic inflammatory diseases

Financial Results Abivax Therapeutics Chronic Inflammatory Diseases EUR 222M

Accesswire

Published on 06/18/2026 at 00:00, 7 hours 16 minutes ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 7 hours 46 minutes ago

Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 8 hours 26 minutes ago

International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 8 hours 46 minutes ago

Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 14 hours 21 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 07:00, 16 minutes ago

Press release: Leonteq concludes regulatory legacy matters
Published on 06/18/2026 at 07:00, 16 minutes ago

Successful virtual Annual General Meeting: Ringmetall SE reports from Munich
Published on 06/18/2026 at 06:40, 36 minutes ago

APES 2026: 2,000+ Chinese Source Factories, One-Stop Direct Sourcing -Maximizing Buyer Margins
Published on 06/18/2026 at 06:30, 46 minutes ago

Schindler Holding Ltd. increases ongoing share buyback program to up to CHF 700 million
Published on 06/18/2026 at 04:05, 3 hours 11 minutes ago

Hisense Brings Smarter Home Experiences to Families During the FIFA World Cup 2026™

Les Echos

Published on 06/18/2026 at 07:00, 16 minutes ago

bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 13 hours 36 minutes ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 22 hours 31 minutes ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 19 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 8 hours ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES

View all LES ECHOS COMFI WIRE